Trinitas DX is a strategic partnership of knowledge institutions and academic entrepreneurs in the field of medical diagnostics. We focus on a future where integrated diagnostics becomes the standard in healthcare, resulting in faster, more accurate diagnoses, and better patient care. The goal is to promote innovations in medical diagnostics through effective and, where possible, combined use of In Vitro Diagnostics (IVD), Imaging (IMG), and Artificial Intelligence (AI).
Trinitas DX operates as a national organization for contract research and clinical studies. We provide entrepreneurs in the field of innovative diagnostics access to a tailor-made academic testing and development environment and a clinical validation environment for high-risk innovations.
The consortium is knowledgeable in the field of common complaints, including neurological complaints, thoracic complaints, persistent (and unexplained) complaints, and musculoskeletal complaints. Trinitas DX can help reduce the barriers for academic entrepreneurship in the field of diagnostics because scientific and patient-related research in practice is the only way to demonstrate the effectiveness of new diagnostics.